Company profile: Curio Bioscience
1.1 - Company Overview
Company description
- Provider of spatial transcriptomics tools for cancer biology, developmental biology, immunology, and neuroscience: Curio Seeker kits for whole transcriptome mapping of fresh-frozen tissues, compatible with eukaryotes and fitting sequencing workflows without specialized equipment; Curio Trekker for single-cell spatial mapping without deconvolution or segmentation; and the Seeker bioinformatics pipeline to process FASTQ into spatial maps.
Products and services
- Curio Seeker Bioinformatics Pipeline: FASTQ-driven pipeline transforms Curio Seeker sequencing libraries into spatial gene expression maps, conducting quality control and preliminary analyses, and interoperates with third-party analysis tools for downstream exploration
- Curio Seeker Spatial Mapping Kits: High-resolution kits enable whole-transcriptome spatial mapping on fresh frozen tissues across diverse eukaryotic organisms, integrating seamlessly into existing sequencing workflows without specialized equipment for adoption
- Curio Trekker Single-Cell Spatial Mapping Kit: Deconvolution-free kit arranges standard single-cell genomics data into spatial orientation at single-cell granularity, avoiding cell segmentation while reconstructing spatial context from conventional datasets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Curio Bioscience
H1
HQ: United States
Website
- Description: Provider of a health data platform supporting end-to-end therapeutic development for medical companies and healthcare systems. Offerings include Trial Landscape for principal investigator pools, site performance and patient diversity insights; GenosAI for querying trial data; HCP Universe to discover and engage HCPs; Precise doctor directory data; and H1 Connect for global humanitarian missions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H1 company profile →
ObvioHealth
HQ: United States
Website
- Description: Provider of a no-code digital platform and app for study design and patient experience visualization; a virtual site team for scheduling, televisits, and personalized participant support; clinical science experts to identify digital endpoints and assist sponsors in achieving robust outcomes; a patient engagement suite combining a mobile app and easy data capture; remote patient monitoring with real-time adverse event detection; and ePRO/eCOA tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ObvioHealth company profile →
PharmaTher
HQ: Canada
Website
- Description: Provider of ketamine-based medicines, developing KETARX (ketamine HCl injection) for anesthesia and procedural sedation via FDA ANDA; a hydrogel microneedle ketamine patch for neuropsychiatric, neurodegenerative and pain disorders; and PD-001, an oral enteric-coated cepharanthine for responsive cancers and infectious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaTher company profile →
Deep Genomics
HQ: Canada
Website
- Description: Provider of an AI platform that analyzes RNA biology, identifies novel targets, and evaluates therapeutic candidates; BigRNA, the first RNA foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates; and BigRNA+, which expands BigRNA to include more genetic mechanisms and diseases for broader therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Genomics company profile →
mProve
HQ: United States
Website
- Description: Provider of mobile technology solutions for the clinical research industry, leveraging a team that has shaped mobile user experiences through high-profile projects, including managing 178 million text message votes for American Idol Season 8 and text messaging solutions for Obama's 2008 presidential campaign.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full mProve company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Curio Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Curio Bioscience
2.2 - Growth funds investing in similar companies to Curio Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Curio Bioscience
4.2 - Public trading comparable groups for Curio Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →